Literature DB >> 22968140

Morphologic changes in the placentas of HIV-positive women and their association with degree of immune suppression.

Anine Vermaak1, Gerhard B Theron, Pawel T Schubert, Martin Kidd, Ursula Rabie, Benedict M Adjiba, Colleen A Wright.   

Abstract

OBJECTIVE: To provide baseline information regarding a possible association between specific histopathologic features of the placentas of HIV-positive women and the degree of immune suppression.
METHODS: A prospective single-blinded laboratory-based pilot study was conducted at Tygerberg Hospital, South Africa. The macroscopic and microscopic features of placentas from HIV-positive (n=91) and HIV-negative women (n=89) were compared and recorded using a standard template. Investigators were blinded to the participants' HIV status and CD4-positive cell count.
RESULTS: Placentas from the HIV-positive group were characterized by decreased weight and increased number of marginal infarcts relative to the HIV-negative group. The most important microscopic finding was the increased presence of villitis of unknown etiology (VUE) among the group of untreated HIV-positive women with CD4 cell counts of 200 cells/mm(3) or below.
CONCLUSION: Both macroscopic and microscopic differences relating to the degree of immune suppression were identified, which seemingly contradicts previous reports. Larger studies are warranted to define the function of antiretroviral therapy and VUE in the mechanism of mother-to-fetus transmission of HIV. Furthermore, the potential role of VUE in the pathophysiology of the compromised immune response observed among HIV-exposed but uninfected infants should be investigated.
Copyright © 2012 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22968140     DOI: 10.1016/j.ijgo.2012.06.016

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  4 in total

1.  Growth at 2 Years of Age in HIV-exposed Uninfected Children in the United States by Trimester of Maternal Antiretroviral Initiation.

Authors:  Denise L Jacobson; Kunjal Patel; Paige L Williams; Mitchell E Geffner; George K Siberry; Linda A DiMeglio; Marilyn J Crain; Ayesha Mirza; Janet S Chen; Elizabeth McFarland; Deborah Kacanek; Margarita Silio; Kenneth Rich; William Borkowsky; Russell B Van Dyke; Tracie L Miller
Journal:  Pediatr Infect Dis J       Date:  2017-02       Impact factor: 2.129

Review 2.  Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants.

Authors:  Jennifer Jao; Elaine J Abrams
Journal:  Pediatr Infect Dis J       Date:  2014-07       Impact factor: 2.129

3.  Brief Report: Chronic Placental Inflammation Among Women Living With HIV in Uganda.

Authors:  Lisa M Bebell; Mark J Siedner; Joseph Ngonzi; Mylinh H Le; Julian Adong; Adeline A Boatin; Ingrid V Bassett; Drucilla J Roberts
Journal:  J Acquir Immune Defic Syndr       Date:  2020-11-01       Impact factor: 3.771

Review 4.  The Effect of Human Immunodeficiency Virus and Cytomegalovirus Infection on Infant Responses to Vaccines: A Review.

Authors:  Olivia Falconer; Marie-Louise Newell; Christine E Jones
Journal:  Front Immunol       Date:  2018-03-02       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.